Muscle Invasive Bladder Cancer
1 competing product in clinical development for Muscle Invasive Bladder Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| pegylated liposomal doxorubicin (PLD) + PD-1 | CSPC Pharmaceutical Group Limited | Phase 2 | UNKNOWN | 51 |